Filing Flows › Bioadaptives (BDPT) › Q4 2025
Bioadaptives (BDPT) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Apr 14, 2026
Bioadaptives (BDPT) reported revenue of $10K for the fourth quarter 2025 (Q4 2025) and +125% from the quarter before.
Bioadaptives, Q4 2025: revenue $10K, net loss $823K, operating cash flow −$156K. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $10K | +125% | — |
| Operating profit | −$248K | — | — |
| Net earnings | −$823K | — | — |
| Operating cash flow | −$156K | — | — |
What changed
Revenue was $10K in Q4 2025, up 125% from the previous quarter.
Gross margin was 72.7%. Operating costs exceeded revenue by $248K, an operating margin of -2379.6%. The quarter ended with a net loss of $823K, wider than the previous quarter's $380K loss. Net interest and other expense of $575K was the main reason.
Operating cash flow was −$156K. Non-cash charges added back $2K of depreciation and amortization. Working capital and other items added $666K.
Questions
What was Bioadaptives' revenue in the fourth quarter 2025?
Bioadaptives (BDPT) reported revenue of $10K for the fourth quarter 2025 (Q4 2025) and +125% from the quarter before.
Source: Bioadaptives 10-K on SEC EDGAR.